Will a Leadership Shake-up at the DOJ Change the Game for Federal Rescheduling?

The cannabis world is moving fast this week, with major shifts happening from the halls of D.C. to local dispensaries. One of the biggest headlines for health-conscious tokers is a new FDA memo regarding Medicare. The agency has signaled it won't push back against a program that covers specific hemp-derived CBD products. This is a massive win for accessibility, especially for seniors who rely on CBD for wellness but have faced high out-of-pocket costs. If you have relatives using CBD for inflammation or sleep, this is definitely news to share.

On the political front, there is a potential shake-up at the Department of Justice. Rumors are swirling that Lee Zeldin might take over as Attorney General. For those of us tracking federal rescheduling, this is a "wait and see" moment. While Zeldin has a varied track record, the momentum for moving cannabis to Schedule III remains strong. Meanwhile, in Massachusetts, the local industry is stepping up to protect progress, filing a lawsuit to keep a legalization rollback off the ballot. It’s a great reminder that staying engaged in local policy is just as important as watching federal news.

Exciting things are also brewing in the nation’s capital. D.C. is looking at a plan to allow partnerships between medical marijuana brands and local craft breweries to create THC-infused, non-alcoholic drinks. Imagine hitting a local spot for a professionally brewed, weed-infused beverage—it’s the kind of innovation that keeps the culture fresh.

Finally, we’re seeing progress in the South. Virginia is staffing up its regulatory team to prepare for adult-use sales, and Texas has greenlit more medical licenses to expand patient access. Even Maryland is looking out for its heroes, passing a bill to ensure firefighters aren't punished for using medical cannabis off the clock. Whether it's better access or cool new products, the community continues to grow in the right direction. Stay informed and stay lifted!